Ernexa Therapeutics, Inc. (ERNA)

1.83 -0.16 (-8.04%) USD  |  NASDAQ  |  Nov 05, 16:00
2.28 +0.45 (+24.59%) After-Hours: 06:21
More

Ernexa Therapeutics SG&A Expense (TTM) : 5.319M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 5.319M
March 31, 2026 5.372M
December 31, 2025 5.162M
September 30, 2025 5.284M
June 30, 2025 7.707M
March 31, 2025 10.24M
December 31, 2024 13.13M
September 30, 2024 16.10M
June 30, 2024 16.70M
March 31, 2024 15.31M
December 31, 2023 14.59M
September 30, 2023 12.86M
June 30, 2023 12.22M
March 31, 2023 15.91M
December 31, 2022 16.84M
September 30, 2022 18.33M
June 30, 2022 19.24M
March 31, 2022 17.62M
December 31, 2021 14.72M
September 30, 2021 11.01M
June 30, 2021 7.843M
March 31, 2021 4.296M
December 31, 2020 3.727M
September 30, 2020 6.542M
June 30, 2020 8.922M
Date Value
March 31, 2020 11.31M
December 31, 2019 13.72M
September 30, 2019 13.72M
June 30, 2019 13.70M
March 31, 2019 13.93M
December 31, 2018 14.49M
September 30, 2018 15.08M
June 30, 2018 15.27M
March 31, 2018 15.47M
December 31, 2017 15.59M
September 30, 2017 15.73M
June 30, 2017 16.10M
March 31, 2017 16.39M
December 31, 2016 16.46M
September 30, 2016 16.31M
June 30, 2016 16.38M
March 31, 2016 17.10M
December 31, 2015 18.06M
September 30, 2015 18.66M
June 30, 2015 19.45M
March 31, 2015 19.16M
December 31, 2014 18.39M
September 30, 2014 17.96M
June 30, 2014 17.15M
March 31, 2014 16.56M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Cerenome, Inc. 18.10M
ACADIA Pharmaceuticals, Inc. 486.89M
Alnylam Pharmaceuticals, Inc. 1.338B
Anika Therapeutics, Inc. 52.67M
Savara, Inc. 56.71M